Nuvilex's Pancreatic Cancer Treatment Readies to Challenge Eli Lilly and Celgene in Late-Phase Clinical Trials
February 19, 2014 09:00 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Feb 19, 2014) - Nuvilex, Inc. (OTCQB: NVLX) is a small biotech firm in Silver Spring, Maryland, that hopes to soon be mentioned with much larger biotechnology and...
Nuvilex, Inc.'s Cell Encapsulation Could Play Role in Multimodality Treatment of Cancer Patients
June 06, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jun 6, 2013) - Nuvilex, Inc. (OTCQB: NVLX) has a technology in its cell encapsulation process that will very likely play some role in the future of oncology. How...
Nuvilex, Inc. Could Become Significant Player in the Oncology Arena With Successful Phase III Trials
May 22, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 22, 2013) - Nuvilex, Inc. (OTCQB: NVLX) is a diamond in the rough in the truest sense. Currently shares of the Silver Spring, Maryland, biotechnology firm can...
Nuvilex, Inc. and Celgene, Corp. Can Both Replace Eli Lilly's Cancer Drug Gemzar
May 20, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 20, 2013) - The race is on, and patients with advanced stage, inoperable pancreatic cancer will be the recipients of the winner's treatment. Two biotechnology...
Nuvilex, Inc. Cell Encapsulation Could Mimic Combination Chemotherapy
May 15, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 15, 2013) - Nuvilex, Inc. (OTCQB: NVLX) has had its living cell encapsulation or "Cell-in-a-Box" technology tested again and again, and each time it has proven it...
Nuvilex, Inc.'s Dr. Gerald Crabtree Discusses Upcoming Phase III Cancer Trials, Fast Track and Orphan Drug Status
May 13, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 13, 2013) - Nuvilex, Inc. (OTCQB: NVLX) COO Dr. Gerald Crabtree is no stranger to late stage clinical trials or dealing with blockbuster therapies for cancer...
BUYINS.NET Updates Nuvilex SqueezeTrigger Report
May 03, 2013 09:00 ET
|
Nuvilex, Inc.
NEWPORT BEACH, CA--(Marketwired - May 3, 2013) - BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity...
Nuvilex, Inc. Pancreatic Cancer Therapy Offers Higher Survival Rate and Less Toxicity Than Competitors
May 02, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 2, 2013) - Nuvilex, Inc. (OTCQB: NVLX) has already produced impressive results from its two independent Phase II clinical trials in patients with advanced,...